Late-breaking Data at ACC.22 with Over 1 Million Patients Demonstrates a Major Gap in Guideline Adherence Resulting in Higher Mortality for Patients with Infected CIEDs

Largest ever real-world analysis of Cardiac Implantable Electronic Device (CIED) infection treatment presented at ACC.22 demonstrates that approximately 4 in 5 patients are not treated according to HRS/EHRA Class I guidelines for CIED infection.

Related Keywords

United States ,Washington ,Coll Cardiol ,Jonathanp Piccini ,Clin Electrophysiol ,Chris Landon ,Sean Pokorney ,Founder Of Arrhythmia Alliance ,European Heart Rhythm Association ,Us Centers For Medicare Medicaid Services ,American College Of Cardiology ,Duke Clinical Research Institute ,Philips ,Duke Heart Center ,Duke University ,Royal Philips ,Medicaid Services ,American College ,Annual Scientific Session ,Assistant Professor ,Duke University School ,Duke Clinical Research ,Cardiac Electrophysiology ,Duke Heart ,Arrhythmia Alliance ,Medicare Study ,Senior Vice President ,General Manager Image Guided Therapy Devices ,Lead Management ,Late Breaking Clinical ,United States April ,Consensus Statement ,Heart Rhythm ,Internal Medicine ,Contemporary Setting ,Multicenter Observational Retrospectivestudy ,Consecutive Laser Lead Extractions ,